Interview with CEO Nils Brünner and CEO Ole Thastrup (2cureX)
BioStock has interviewed CEO Nils Brünner, Scandion Oncology, and CEO Ole Thastrup, 2cureX, about the Eurostars project on antiestrogen resistance.
The full interview is freely available here: https://www.biostock.se/2020/06/scandion-oncology-och-2curex-erhaller-bidrag-fran-eurostars/

